BioVectra and PhaseBio Discuss Creating an Optimal Partnership

BioVectra's Oliver Technow and PhaseBio's Jonathan Mow discuss their new supply agreement and the essential elements for an effective partnership.

Oliver Technow

With more than 20 years of global pharmaceutical industry experience, Oliver Technow, CEO of BioVectra, has held numerous leadership positions in commercial development, marketing and brand management and life cycle management in Europe and North America, and was appointed President of BioVectra Inc. on December 10, 2015 and became CEO in November 2019. He holds an industry master’s degree from Frankfurt Chamber of Commerce, Frankfurt Germany.